Drug
Zyh7
Zyh7: highest development phase Phase 2, developed by Zydus. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Zydus
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZYH7 NCT01539616 | Phase 2 | Hypertriglyceridemia |
Latest
No recent events.
Follow Zyh7 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.